Notice of Compliance Information
From Health Canada
- Notice of Compliance date :
- 2023-12-06
- Manufacturer :
- PFIZER CANADA ULC
- Product type:
- Biologic
- NOC with conditions:
- Yes
- Submission type:
- New Drug Submission (NDS)
- Submission class:
- New Active Substance (NAS)
Brand 1 of 1 :
ELREXFIO
Product 1 of 2 :
Drug identification number:
02543567
Dosage form(s):
Solution
Route(s) of administration:
Subcutaneous
| Ingredient | Strength |
|---|---|
| ELRANATAMAB | 76 MG/1.9ML |
Product 2 of 2 :
Drug identification number:
02543559
Dosage form(s):
Solution
Route(s) of administration:
Subcutaneous
| Ingredient | Strength |
|---|---|
| ELRANATAMAB | 44 MG/1.1ML |